The conclusion of the trial was based on a strict temperature control below 36 C to prevent hyperthermia, which is considered a determining factor for poor prognosis.Emphasis was also placed on the establishment of standardized protocols, even for each subgroup of patients who may benefit from individualized treatment.
La conclusión del estudio estriba en el manejo estricto de la temperatura por debajo de 36 C para que no se vaya a presentar hipertermia, que se considera un factor determinante de mal pronóstico.